Mackie downgraded shares of Spectral Medical Inc (TSE:EDT) from a speculative buy rating to a sell rating in a research report report published on Monday.
A number of other equities analysts also recently commented on the company. GMP Securities restated a speculative buy rating on shares of Spectral Medical in a report on Wednesday, September 14th. Cormark downgraded Spectral Medical from a buy rating to a reduce rating in a report on Monday.
Spectral Medical (TSE:EDT) opened at 0.24 on Monday. The firm has a 50-day moving average price of $1.19 and a 200 day moving average price of $1.01. Spectral Medical has a 52-week low of $0.18 and a 52-week high of $2.07. The firm’s market capitalization is $49.62 million.